The combination of photothermal therapy and chemical drug therapy shows good prospects in cancer treatment, but there are also some limitations such as low permeability of therapeutic agents and uneven photothermal therapy. Here, we synthesized a walnut-shaped polydopamine (PDA) nanomotor driven by near infrared (NIR) light. The nanomotor was modified by methoxy polyethylene glycol amine (mPEG-NH 2 ) for improving water solubility. PDA-PEG loaded adriamycin through π−π accumulation and hydrogen bonding. The experimental results showed that the PDA nanomotors had good biocompatibility and photothermal effect. Further, the NIR light irradiation and tumor cell microenvironment are conducive to drug release. In addition, under the irradiation of an NIR laser, the asymmetry of walnut-shaped nanoparticles makes the particles obtain the ability of autonomous movement, which can improve the permeability of particles in 3D tumor balls, which can provide support for drug penetration and heat dispersion. This strategy offers potential innovative materials for photothermal/chemotherapy synergistic therapy of tumors.
A kind of drug-loaded nanomotors with deep penetration
was developed
to improve the therapeutic effect of ferroptosis on tumor. The nanomotors
were constructed by co-loading hemin and ferrocene (Fc) on the surface
of bowl-shaped polydopamine (PDA) nanoparticles. The near-infrared
response of PDA makes the nanomotor have high tumor penetration capability. In vitro experiments show that the nanomotors can exhibit
good biocompatibility, high light to heat conversion efficiency, and
deep tumor permeability. It is worth noting that under the catalysis
of H2O2 overexpressed in the tumor microenvironment,
the Fenton-like reagents hemin and Fc loaded on the nanomotors can
increase the concentration of toxic •OH. Furthermore, hemin
can consume glutathione in tumor cells and trigger the up-regulation
of heme oxygenase-1, which can efficiently decompose hemin to Fe2+, thus producing the Fenton reaction and causing a ferroptosis
effect. Notably, thanks to the photothermal effect of PDA, it can
enhance the generation of reactive oxygen species and thus intervene
in the Fenton reaction process, thereby enhancing the ferroptosis
effect photothermally. In vivo antitumor results
show that the drug-loaded nanomotors with high penetrability showed
an effective antitumor therapeutic effect.
The drug-resistance of bacteria has posed a serious threat to public health, so the exploration of new antibacterial materials has attracted extensive attention. Here, we reported Au@ZnO@SiO2-ICG nanomotors as an...
Due to their complexity and variability, tumors need to be treated with multimodal combined therapy, which requires the development of therapeutic agents that can provide multimodal therapeutic effects. Here, CuMoO4 nanodots smaller than 10 nm that can be prepared by simple hydrothermal method are reported. These nanodots can be well dispersed in water and have good biosafety and biodegradability. Further studies show that these nanodots also present multienzyme activities, such as catalase, peroxidase and glutathione peroxidase. In addition, CuMoO4 nanodots exhibit high photothermal conversion efficiency (41%) under 1064 nm near‐infrared laser irradiation. In vitro and in vivo experimental results indicate that CuMoO4 nanodots can effectively inhibit the instinctive regulation of tumor cells to oxidative stress, provide sustained treatment to achieve photothermal synergistic ferroptosis, and trigger immune responses to immunogenic cell death. It is worth mentioning that the CuMoO4 nanodots also cause cuproptosis of tumor cells. This study provides a promising nanoplatform for multimodal combined therapy of cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.